Publication:
Dual sensitive and rapid detection of glycated human serum albumin using a versatile lead/graphene nanocomposite probe as a fluorescence-electrochemical aptasensor

dc.contributor.authorThitirat Putninen_US
dc.contributor.authorWassa Waiwinyaen_US
dc.contributor.authorDechnarong Pimalaien_US
dc.contributor.authorWireeya Chawjiraphanen_US
dc.contributor.authorNuankanya Sathirapongsasutien_US
dc.contributor.authorDeanpen Japrungen_US
dc.contributor.otherThailand National Nanotechnology Centeren_US
dc.contributor.otherFaculty of Medicine Ramathibodi Hospital, Mahidol Universityen_US
dc.date.accessioned2022-08-04T08:07:28Z
dc.date.available2022-08-04T08:07:28Z
dc.date.issued2021-07-07en_US
dc.description.abstractMonitoring of glycated human serum albumin (GHSA) as a glycemic marker for screening and monitoring of diabetes mellitus is widely practiced for patients with conditions that affect red blood cells. In this study, a complex comprising Pb ions adsorbed on graphene oxide (GO-Pb) was fabricated and utilized as a versatile probe in a fluorescence-electrochemical aptasensor for GHSA quantification. To simplify the aptasensor, the GO-Pb complex probe was prepared via an ion adsorption process. After modification with a fluorophore-labeled aptamer, the GO-Pb complex served as an excellent energy acceptor in fluorescence-based analysis, as well as generating a high current in the electrochemical transducer. Additionally, the proposed platform can detect GHSA via the dual technique from a single sample, allowing for precise and accurate results. Under optimal conditions, the fluorescence-electrochemical aptasensor exhibited a linear relationship with GHSA concentrations from 0.001 to 80 μg mL-1 and from 0.005 to 10 μg mL-1 for fluorescence and electrochemical detection, respectively. The corresponding detection limits were 8.80 ng mL-1 and 0.77 ng mL-1, respectively. The proposed aptasensor additionally displayed good selectivity and excellent stability. Moreover, its successful application in the analysis of clinical samples further demonstrated its utility. Therefore, the proposed platform has significant potential as a novel, facile, highly responsive, and low-cost monitoring method for the development of diabetes mellitus diagnostic devices intended for a clinical setting. This journal isen_US
dc.identifier.citationAnalyst. Vol.146, No.13 (2021), 4357-4364en_US
dc.identifier.doi10.1039/d1an00556aen_US
dc.identifier.issn13645528en_US
dc.identifier.issn00032654en_US
dc.identifier.other2-s2.0-85109005365en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/76106
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85109005365&origin=inwarden_US
dc.subjectBiochemistry, Genetics and Molecular Biologyen_US
dc.subjectChemistryen_US
dc.subjectEnvironmental Scienceen_US
dc.titleDual sensitive and rapid detection of glycated human serum albumin using a versatile lead/graphene nanocomposite probe as a fluorescence-electrochemical aptasensoren_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85109005365&origin=inwarden_US

Files

Collections